These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 33784233)

  • 1. Chronotropic Index and Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Secondary Analysis of BLOCK COPD.
    MacDonald DM; Helgeson ES; Adabag S; Casaburi R; Connett JE; Stringer WW; Voelker H; Dransfield MT; Kunisaki KM
    Ann Am Thorac Soc; 2021 Nov; 18(11):1795-1802. PubMed ID: 33784233
    [No Abstract]   [Full Text] [Related]  

  • 2. Lung Function and the Risk of Exacerbation in the β-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease Trial.
    Parekh TM; Helgeson ES; Connett J; Voelker H; Ling SX; Lazarus SC; Bhatt SP; MacDonald DM; Mkorombindo T; Kunisaki KM; Fortis S; Kaminsky D; Dransfield MT
    Ann Am Thorac Soc; 2022 Oct; 19(10):1642-1649. PubMed ID: 35363600
    [No Abstract]   [Full Text] [Related]  

  • 3. Metoprolol for the Prevention of Acute Exacerbations of COPD.
    Dransfield MT; Voelker H; Bhatt SP; Brenner K; Casaburi R; Come CE; Cooper JAD; Criner GJ; Curtis JL; Han MK; Hatipoğlu U; Helgeson ES; Jain VV; Kalhan R; Kaminsky D; Kaner R; Kunisaki KM; Lambert AA; Lammi MR; Lindberg S; Make BJ; Martinez FJ; McEvoy C; Panos RJ; Reed RM; Scanlon PD; Sciurba FC; Smith A; Sriram PS; Stringer WW; Weingarten JA; Wells JM; Westfall E; Lazarus SC; Connett JE;
    N Engl J Med; 2019 Dec; 381(24):2304-2314. PubMed ID: 31633896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural History of Chronic Obstructive Pulmonary Disease Exacerbations in a General Practice-based Population with Chronic Obstructive Pulmonary Disease.
    Rothnie KJ; Müllerová H; Smeeth L; Quint JK
    Am J Respir Crit Care Med; 2018 Aug; 198(4):464-471. PubMed ID: 29474094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting Re-Exacerbation Timing and Understanding Prolonged Exacerbations: An Analysis of Patients with COPD in the ECLIPSE Cohort.
    Meeraus WH; Mullerova H; El Baou C; Fahey M; Hessel EM; Fahy WA
    Int J Chron Obstruct Pulmon Dis; 2021; 16():225-244. PubMed ID: 33574663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart Rate Variability on 10-Second Electrocardiogram and Risk of Acute Exacerbation of COPD: A Secondary Analysis of the BLOCK COPD Trial.
    MacDonald DM; Mkorombindo T; Ling SX; Adabag S; Casaburi R; Connett JE; Helgeson ES; Porszasz J; Rossiter HB; Stringer WW; Voelker H; Zhao D; Dransfield MT; Kunisaki KM
    Chronic Obstr Pulm Dis; 2022 Apr; 9(2):226-236. PubMed ID: 35403415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
    Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
    Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
    [No Abstract]   [Full Text] [Related]  

  • 8. Association of Upon-Diagnosis Blood Eosinophilic Count with Frequency and Severity of Annual Exacerbation in Chronic Obstructive Pulmonary Disease: A Prospective Longitudinal Analysis.
    Kiani A; Rahimi F; Afaghi S; Paat M; Varharam M; Dizaji MK; Dastoorpoor M; Abedini A
    Can Respir J; 2023; 2023():8678702. PubMed ID: 37153722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between P-pulmonale and respiratory morbidity in COPD: a secondary analysis of the BLOCK-COPD trial.
    Wade RC; Mkorombindo T; Ling SX; Helgeson ES; MacDonald DM; Pew K; Voelker H; Bittner V; Kunisaki KM; Lammi MR; Dransfield MT
    BMC Pulm Med; 2023 Nov; 23(1):434. PubMed ID: 37946165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).
    Ni H; Htet A; Moe S
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011897. PubMed ID: 28631387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease.
    Maqsood U; Ho TN; Palmer K; Eccles FJ; Munavvar M; Wang R; Crossingham I; Evans DJ
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012930. PubMed ID: 30839102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocol.
    Bhatt SP; Connett JE; Voelker H; Lindberg SM; Westfall E; Wells JM; Lazarus SC; Criner GJ; Dransfield MT
    BMJ Open; 2016 Jun; 6(6):e012292. PubMed ID: 27267111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microalbuminuria on admission for acute exacerbation of COPD as a predictor of all-cause mortality and future exacerbations.
    Bartziokas K; Kyriakopoulos C; Dounousi E; Kostikas K
    Postgrad Med J; 2023 May; 99(1169):189-197. PubMed ID: 37222052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
    Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azithromycin during Acute Chronic Obstructive Pulmonary Disease Exacerbations Requiring Hospitalization (BACE). A Multicenter, Randomized, Double-Blind, Placebo-controlled Trial.
    Vermeersch K; Gabrovska M; Aumann J; Demedts IK; Corhay JL; Marchand E; Slabbynck H; Haenebalcke C; Haerens M; Hanon S; Jordens P; Peché R; Fremault A; Lauwerier T; Delporte A; Vandenberk B; Willems R; Everaerts S; Belmans A; Bogaerts K; Verleden GM; Troosters T; Ninane V; Brusselle GG; Janssens W
    Am J Respir Crit Care Med; 2019 Oct; 200(7):857-868. PubMed ID: 31046405
    [No Abstract]   [Full Text] [Related]  

  • 16. Exploring Patterns of COPD Exacerbations and Comorbid Flare-Ups.
    van Dijk SHB; Brusse-Keizer MGJ; Effing T; van der Valk PDLPM; Ploumen EH; van der Palen J; Doggen CJM; Lenferink A
    Int J Chron Obstruct Pulmon Dis; 2023; 18():2633-2644. PubMed ID: 38022827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-IL-5 therapies for chronic obstructive pulmonary disease.
    Donovan T; Milan SJ; Wang R; Banchoff E; Bradley P; Crossingham I
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013432. PubMed ID: 33295032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins versus placebo for people with chronic obstructive pulmonary disease.
    Walsh A; Perrem L; Khashan AS; Henry MT; Ni Chroinin M
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD011959. PubMed ID: 31425628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terms and Definitions Used to Describe Recurrence, Treatment Failure and Recovery of Acute Exacerbations of COPD: A Systematic Review of Observational Studies.
    Meeraus WH; DeBarmore BM; Mullerova H; Fahy WA; Benson VS
    Int J Chron Obstruct Pulmon Dis; 2021; 16():3487-3502. PubMed ID: 34992357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based study.
    Ho TW; Tsai YJ; Ruan SY; Huang CT; Lai F; Yu CJ;
    PLoS One; 2014; 9(12):e114866. PubMed ID: 25490399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.